Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases

被引:39
|
作者
Giannelli, G
Pierri, F
Trerotoli, P
Marinosci, F
Serio, G
Schiraldi, O
Antonaci, S
机构
[1] Univ Bari, Sch Med, Sect Med Stat, Dept Internal Med & Publ Hlth, Bari, Italy
[2] Univ Bari, Sch Med, Sect Internal Med, Dept Internal Med Immunol & Infect Dis, Bari, Italy
关键词
hepatocellular carcinoma; metastasis; prognostic factors; tumor invasion; blood vessel metastasis; multivariate analysis;
D O I
10.1016/S1386-6346(02)00027-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. Despite improvements in diagnostic and therapeutic interventions, prognosis and survival are still poor. To identify factors influencing survival, we retrospectively examined 150 consecutive patients with HCC from the time of first diagnosis of cirrhosis to death. In a multivariate analysis, we found that patients with larger HCC lesions had shorter survival, while other pathologic features had no predictive value. The most important and reliable prognostic factor was the occurrence of tumor thrombus of the portal vein (P < 0.01). Child's stage of underlying liver disease was relevant only in the univariate, but not in the multivariate analysis. The survival of patients with HCC is mainly affected by the biological ability of cancer cells to invade surrounding tissue and vessels. More studies are needed to elucidate the mechanisms that modulate tumor cell motility, in order to design more effective therapies. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:50 / 59
页数:10
相关论文
共 50 条
  • [21] Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma
    Ju-Xian Sun
    Jie Shi
    Nan Li
    Wei-Xing Guo
    Meng-Chao Wu
    Wan-Yee Lau
    Shu-Qun Cheng
    Cancer Biology & Medicine, 2016, (04) : 452 - 458
  • [22] Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
    Jie Shi
    Eric C. H. Lai
    Nan Li
    Wei-Xing Guo
    Jie Xue
    Wan Yee Lau
    Meng-Chao Wu
    Shu-Qun Cheng
    Annals of Surgical Oncology, 2010, 17 : 2073 - 2080
  • [23] A new classification for hepatocellular carcinoma with portal vein tumor thrombus
    Shi, Jie
    Lai, Eric C. H.
    Li, Nan
    Guo, Wei-Xing
    Xue, Jie
    Lau, Wan-Yee
    Wu, Meng-Chao
    Cheng, Shu-Qun
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2011, 18 (01) : 74 - 80
  • [24] Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomy
    Chai, Zong-Tao
    Zhang, Xiu-Ping
    Shao, Min
    Ao, Jian-Yang
    Chen, Zhen-Hua
    Zhang, Fan
    Hu, Yi-Ren
    Zhong, Cheng-Qian
    Lin, Jian-Hua
    Fang, Kun-Peng
    Wu, Meng-Chao
    Lau, Wan Yee
    Cheng, Shu-Qun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
  • [25] A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
    Xiao, Cheng-Zuo
    Wei, Wei
    Guo, Zhi-Xing
    Li, Shu-Hong
    Zhang, Yong-Fa
    Wang, Jia-Hong
    Shi, Ming
    Guo, Rong-Ping
    ONCOLOGY LETTERS, 2015, 10 (05) : 2787 - 2794
  • [26] The impact of sphingosine kinase 1 on the prognosis of hepatocellular carcinoma patients with portal vein tumor thrombus
    Shi, Jie
    He, Yong-yong
    Sun, Ju-Xian
    Guo, Wei-Xing
    Li, Nan
    Xue, Jie
    Cheng, Shu-Qun
    ANNALS OF HEPATOLOGY, 2015, 14 (02) : 198 - 206
  • [27] Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses?
    Feng, Jin-Kai
    Sun, Ju-Xian
    Liu, Zong-Han
    Cheng, Shu-Qun
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 987 - 988
  • [28] Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
    Fan, Wenzhe
    Yuan, Guosheng
    Fan, Huishuang
    Li, Fuliang
    Wu, Yanqin
    Zhao, Yue
    Yao, Wang
    Wang, Yu
    Xue, Miao
    Yang, Jianyong
    Li, Jiaping
    CLINICAL THERAPEUTICS, 2019, 41 (08) : 1463 - 1476
  • [29] Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus
    Ye, Jia-Zhou
    Zhang, Yong-Quan
    Ye, Hai-Hong
    Bai, Tao
    Ma, Liang
    Xiang, Bang-De
    Li, Le-Qun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (45) : 17141 - 17147
  • [30] Survival benefit of TACE combined with sorafenib for hepatocellular carcinoma patients with portal vein tumor thrombus
    Luo, Bin
    Chen, Zhen-Hua
    Zhang, Xiu-Ping
    Wang, Meng
    Cheng, Shu-Qun
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S293 - S295